• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Bioxcel Therapeutics Inc (NQ: BTAI )

    0.6029 +0.0686 (+12.84%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 774,196
    Open 0.5400
    Bid (Size) 0.5810 (12)
    Ask (Size) 0.6000 (34)
    Prev. Close 0.5343
    Today's Range 0.5352 - 0.6168
    52wk Range 0.5050 - 5.620
    Shares Outstanding 40,743,762
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    BTAI Stock Earnings: BioXcel Therapeutics Beats EPS, Beats Revenue for Q2 2024
    BTAI stock results show that BioXcel Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    BioXcel Therapeutics' Approved Drug For Bipolar Disorders/Schizophrenia Shows No Evidence Of Worsening Or Withdrawal In Post-Marketing Study
    BioXcel Therapeutics shares topline results from an Igalmi (dexmedetomidine) sublingual film study. The 180 mcg dose demonstrated favorable safety and efficacy in reducing agitation symptoms. 
    Via Benzinga

    Performance

    YTD
    -79.42%
    -79.42%
    1 Month
    -8.51%
    -8.51%
    3 Month
    -52.53%
    -52.53%
    6 Month
    -78.62%
    -78.62%
    1 Year
    -78.00%
    -78.00%

    More News

    Read More
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    BTAI Stock Earnings: BioXcel Therapeutics Misses EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    BioXcel Therapeutics's Earnings Outlook
    Via Benzinga
    Why BioXcel Therapeutics Shares Are Falling Today
    Via Benzinga
    AI Surge Has Ended: All 7 AI Stock Categories Declined This Week
    Via Talk Markets
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Six Of Seven AI Stock Categories Increased This Week
    Via Talk Markets
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    7 Short-Squeeze Stocks That Could Send the Bears Into Panic-Mode
    Via InvestorPlace
    AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD
    Via Talk Markets
    Earnings Scheduled For March 12, 2024
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics
    Via Talk Markets
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Leading The Charge: Tonix Pharmaceuticals And The Future Of CNS Therapeutics
    Via Get News
    Why BioXcel Therapeutics Shares Are Rising Tuesday
    Via Benzinga
    Exposures Product Safety
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies
    Via FinancialNewsMedia
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies
    From FN Media Group LLC
    Via GlobeNewswire
    BIOXCEL ALERT: Bragar Eagel & Squire, P.C. is Investigating BioXcel Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Why Is CleanSpark (CLSK) Stock Up 27% Today?
    Via InvestorPlace
    Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.